Contribution of antibodies against IA-2β and zinc transporter 8 to classification of diabetes diagnosed under 40 years of age

Diabetes Care

Volumn 34, Issue 8, 2011, Pages 1760-1765

  Vermeulen, Ilse ^a   Weets, Ilse ^a,b   Asanghanwa, Milca ^a   Ruige, Johannes ^c   Van Gaal, Luc ^d   Mathieu, Chantal ^e   Keymeulen, Bart ^a   Lampasona, Vito ^f   Wenzlau, Janet M ^g   Hutton, John C ^g   Pipeleers, Daniel G ^a   Gorus, Frans K ^a,b  

^a DIABETES RESEARCH CENTER   (Belgium)

^b UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f SAN RAFFAELE HOSPITAL   (Italy)

^g UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; INSULIN ANTIBODY; INSULINOMA ASSOCIATED ANTIGEN 2; UNCLASSIFIED DRUG; ZINC TRANSPORTER; ZINC TRANSPORTER 8; CATION TRANSPORT PROTEIN; ICA512 AUTOANTIBODY; RECEPTOR LIKE PROTEIN TYROSINE PHOSPHATASE; SLC30A8 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY DETECTION; ARTICLE; BINDING ASSAY; CHILD; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE REGISTRY; FEMALE; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT ASSESSMENT; PHENOTYPE; PREVALENCE; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; CLASSIFICATION; IMMUNOLOGY;

ADOLESCENT; ADULT; AUTOANTIBODIES; CATION TRANSPORT PROTEINS; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; MALE; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 8; YOUNG ADULT;

EID: 84855872623     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-2268     Document Type: Article

References (25)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997;20:1183-1197
2. Leslie RD, Delli Castelli M. Age-dependent influences on the origins of autoimmune diabetes: evidence and implications. Diabetes 2004;53:3033-3040 (Pubitemid 39571713)
3. Gorus FK. Diabetes registries and early biological markers of insulin-dependent diabetes mellitus. Belgian Diabetes Registry. Diabetes Metab Rev 1997;13:247-274 (Pubitemid 28080806)
4. Bingley PJ. Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab 2010;95:25-33
5. Knip M, Siljander H. Autoimmune mechanisms in type 1 diabetes. Autoimmun Rev 2008;7:550-557
6. Gianani R, Eisenbarth GS. The stages of type 1A diabetes: 2005. Immunol Rev 2005;204:232-249 (Pubitemid 40460505)
7. Winter WE, Harris N, Schatz D. Type 1 diabetes islet autoantibody markers. Diabetes Technol Ther 2002;4:817-839 (Pubitemid 36172465)
8. Wenzlau JM, Frisch LM, Gardner TJ, Sarkar S, Hutton JC, Davidson HW. Novel antigens in type 1 diabetes: the importance of ZnT8. Curr Diab Rep 2009;9:105-112
9. Weets I, Siraux V, Daubresse JC, et al.; Belgian Diabetes Registry. Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood. J Clin Endocrinol Metab 2002;87:2597-2605 (Pubitemid 34655320)
10. Lu J, Li Q, Xie H, et al. Identification of a second transmembrane protein tyrosine phosphatase, IA-2beta, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 1996;93:2307-2311
11. Hawkes CJ, Wasmeier C, Christie MR, Hutton JC. Identification of the 37-kDa antigen in IDDM as a tyrosine phosphatase-like protein (phogrin) related to IA-2. Diabetes 1996;45:1187-1192 (Pubitemid 26296317)
12. Kawasaki E, Eisenbarth GS, Wasmeier C, Hutton JC. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2. Diabetes 1996;45:1344-1349 (Pubitemid 26332896)
13. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci USA 2007;104:17040-17045 (Pubitemid 350210987)
14. Achenbach P, Bonifacio E, Williams AJ, Ziegler AG, Gale EA, Bingley PJ; ENDIT Group. Autoantibodies to IA-2beta improve diabetes risk assessment in high-risk relatives. Diabetologia 2008;51:488-492
15. De Grijse J, Asanghanwa M, Nouthe B, et al.; Belgian Diabetes Registry. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials. Diabetologia 2010;53:517-524
16. Kyvik KO, Nystrom L, Gorus F, et al. The epidemiology of Type 1 diabetes mellitus is not the same in young adults as in children. Diabetologia 2004;47:377-384 (Pubitemid 38491232)
17. Weets I, Truyen I, Verschraegen I, et al.; Belgian Diabetes Registry. Sex- and season-dependent differences in C-peptide levels at diagnosis of immune-mediated type 1 diabetes. Diabetologia 2006;49:1158-1162
18. Rønningen KS, Keiding N, Green A; EURODIAB ACE Study Group. Europe and Diabetes. Correlations between the incidence of childhood-onset type I diabetes in Europe and HLA genotypes. Diabetologia 2001;44(Suppl. 3):B51-B59 (Pubitemid 33015912)
19. Pihoker C, Gilliam LK, Hampe CS, Lernmark Å. Autoantibodies in diabetes. Diabetes 2005;54(Suppl. 2):S52-S61 (Pubitemid 43343331)
20. Van der Auwera B, Schuit F, Lyaruu I, et al. Genetic susceptibility for insulin-dependent diabetes mellitus in Caucasians revisited: the importance of diabetes registries in disclosing interactions between HLA-DQ- and insulin gene-linked risk. Belgian Diabetes Registry. J Clin Endocrinol Metab 1995;80:2567-2573
21. Wenzlau JM, Liu Y, Yu L, et al. A common nonsynonymous single nucleotide polymorphism in the SLC30A8 gene determines ZnT8 autoantibody specificity in type 1 diabetes. Diabetes 2008;57:2693-2697
22. Lampasona V, Petrone A, Tiberti C, et al Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study Group. Zinc transporter 8 antibodies complement GAD and IA-2 antibodies in the identification and characterisation of adult-onset autoimmune diabetes (NIRAD) 4. Diabetes Care 2010;33:104-108
23. Vaziri-Sani F, Oak S, Radtke J, et al. ZnT8 autoantibody titers in type 1 diabetes patients decline rapidly after clinical onset. Autoimmunity 2010;43:598-606
24. Achenbach P, Bonifacio E, Koczwara K, Ziegler A. Natural history of type 1 diabetes. Diabetes 2005;53 (Suppl. 2):S25-S31 (Pubitemid 43343328)
25. Wenzlau JM, Walter M, Gardner TJ, et al. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects. J Clin Endocrinol Metab 2010;95:4712-4719